At Janssen, we are dedicated to addressing some of the most important unmet medical needs in oncology, immunology, neuroscience, infectious diseases and vaccines, and cardiovascular and metabolic diseases. Driven by our commitment to patients, we develop innovative products, services and healthcare solutions to help people throughout the world. Janssen-Cilag International NV is part of the Janssen Pharmaceutical Companies of Johnson & Johnson
Bioclinica is divided into three business segments so that we can provide expert service and multifaceted technologies.
Our Medical Imaging and Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Biomarker Laboratory.
Our eHealth segment comprises an eClinical Solutions Division along with Safety and Regulatory Solutions.
Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a post-approval research division.